CFTR and central nervous system cancer: Previous study reported that FDA-approved drug ivacaftor targets cystic fibrosis transmembrane conductance regulator (CFTR) to treat cystic fibrosis, and CFTR has been indicated to facilitate glioma progression (Zhao et al., 2020).